Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 516 Cr.
- Current Price ₹ 211
- High / Low ₹ 225 / 140
- Stock P/E 24.8
- Book Value ₹ 49.4
- Dividend Yield 0.00 %
- ROCE 28.4 %
- ROE 25.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 71.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.4%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -20.5%
- Working capital days have increased from 52.3 days to 139 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | |
| 60 | 51 | 69 | 67 | 75 | 92 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 37 |
| OPM % | 9% | 9% | 4% | 12% | 25% | 29% |
| 0 | 0 | 0 | 0 | 1 | 1 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% |
| 1 | 1 | -1 | 4 | 16 | 21 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 71% |
| 3 Years: | 154% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 29% |
| Last Year: | 26% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 |
| 15 | 14 | 15 | 17 | 29 | 33 | |
| 20 | 18 | 22 | 26 | 26 | 23 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 95 | 177 |
| 20 | 20 | 25 | 28 | 44 | 71 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 4 |
| Investments | 20 | 11 | 14 | 15 | 13 | 10 |
| 19 | 25 | 21 | 27 | 39 | 91 | |
| Total Assets | 59 | 56 | 59 | 70 | 95 | 177 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 3 | -19 | ||
| 7 | -10 | -2 | -11 | -36 | ||
| -0 | -2 | -2 | 9 | 60 | ||
| Net Cash Flow | 0 | -4 | 1 | 0 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 89 | 88 |
| Inventory Days | 88 | 78 | 37 | 9 | 179 | 317 |
| Days Payable | 126 | 224 | 233 | 399 | 149 | 192 |
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 119 | 214 |
| Working Capital Days | -33 | 34 | -16 | -25 | 43 | 139 |
| ROCE % | 9% | 2% | 18% | 41% | 28% |
Documents
Announcements
-
Statement of deviation(s) or variation(s) under Reg. 32
29 May 2025 - No deviation in utilization of Rs.70.7 Cr IPO funds for diagnostic centers and corporate purposes.
-
Outcome of Board Meeting
28 May 2025 - Approved audited standalone and consolidated financial results for FY ended March 31, 2025, with unmodified audit opinion.
-
Outcome of Board Meeting
27 May 2025 - Audited standalone and consolidated financial results for FY ended March 31, 2025 approved and disclosed.
-
Integrated Filing- Financial
27 May 2025 - Approved and published audited standalone and consolidated financial results for FY ended March 31, 2025.
-
Board Meeting Intimation
17 May 2025 - CHANDAN HEALTHCARE LIMITED has informed about Board Meeting to be held on 27-May-2025 to inter-alia consider and approve the Audited Financial results of the Company …
Annual reports
No data available.
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points